M3, Inc. (MTHRY)

OTCMKTS · Delayed Price · Currency is USD
7.96
+0.07 (0.89%)
Sep 12, 2025, 3:58 PM EDT
0.89%
Market Cap10.87B
Revenue (ttm)2.13B
Net Income (ttm)286.05M
Shares Outn/a
EPS (ttm)0.42
PE Ratio38.00
Forward PEn/a
Dividend0.14 (1.79%)
Ex-Dividend DateMar 28, 2025
Volume496
Average Volume14,956
Open8.00
Previous Close7.89
Day's Range7.92 - 8.05
52-Week Range4.01 - 8.30
Beta0.92
RSI59.15
Earnings DateNov 12, 2025

About M3, Inc.

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through the Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only website for providing information to healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; AskDoctors, where registered doctors answer questions about health and illness fr... [Read more]

Sector Healthcare
Founded 2000
Employees 15,360
Stock Exchange OTCMKTS
Ticker Symbol MTHRY
Full Company Profile

Financial Performance

In 2024, M3, Inc.'s revenue was 284.90 billion, an increase of 19.26% compared to the previous year's 238.88 billion. Earnings were 40.48 billion, a decrease of -10.57%.

Financial numbers in JPY Financial Statements

News

M3, Inc.: Stand-Out Success Story Of Japanese Internet

M3 was a clear beneficiary of the pandemic which has accelerated digitization of pharmaceuticals marketing on its online platform business.

4 years ago - Seeking Alpha

5 Health Care Stocks Growing Fast

Investors may be interested in the following health care companies, as they have expanded their revenue per share and Ebitda per share by more than 10% over the trailing five-year and 10-year periods ...

4 years ago - GuruFocus

5 Telehealth Stocks for Long-Term Financial Fitness

There are no silver linings to the pandemic. Nevertheless, some stocks and sectors have benefited greatly from the societal changes COVID-19 has wrought.

5 years ago - Kiplinger